tetradecanoylphorbol acetate and Dyslipidemia

tetradecanoylphorbol acetate has been researched along with Dyslipidemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abe, M; Aihara, K; Akaike, M; Azuma, H; Hashizume, S; Ikeda, Y; Ishikawa, K; Iwase, T; Matsumoto, T; Sata, M; Sumitomo-Ueda, Y; Yagi, S; Yoshida, S	1

Other Studies

1 other study(ies) available for tetradecanoylphorbol acetate and Dyslipidemia

Article	Year
Activation of peroxisome proliferator-activated receptor α in megakaryocytes reduces platelet-derived growth factor-BB in platelets. Journal of atherosclerosis and thrombosis, 2011, Volume: 18, Issue:2 Topics: Adult; Becaplermin; Blood Platelets; Cell Differentiation; Cell Line, Tumor; Dyslipidemias; Female; Fenofibrate; Gene Expression; Humans; Immunohistochemistry; Lipids; Male; Megakaryocytes; Middle Aged; Platelet-Derived Growth Factor; PPAR alpha; Proto-Oncogene Proteins c-sis; Pyrimidines; RNA, Messenger; Tetradecanoylphorbol Acetate	2011

Article

Year

Activation of peroxisome proliferator-activated receptor α in megakaryocytes reduces platelet-derived growth factor-BB in platelets.

Journal of atherosclerosis and thrombosis, 2011, Volume: 18, Issue:2

Topics: Adult; Becaplermin; Blood Platelets; Cell Differentiation; Cell Line, Tumor; Dyslipidemias; Female; Fenofibrate; Gene Expression; Humans; Immunohistochemistry; Lipids; Male; Megakaryocytes; Middle Aged; Platelet-Derived Growth Factor; PPAR alpha; Proto-Oncogene Proteins c-sis; Pyrimidines; RNA, Messenger; Tetradecanoylphorbol Acetate

2011